Cargando…
Targeted Therapies for Metastatic Esophagogastric Cancer
The prognosis and long-term survival for patients with metastatic esophagogastric cancer (EGC) is poor. Historically, the mainstay of treatment has been combination chemotherapy. More recently, a number of targeted therapies have been developed and are being studied with the goal of improving respon...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066394/ https://www.ncbi.nlm.nih.gov/pubmed/21298375 http://dx.doi.org/10.1007/s11864-011-0138-4 |